Immunovant shares owned by Tower Research Capital
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $373k | 14k | 26.40 |
| 2024-03-31 | $17k | 512 | 32.31 |
| 2023-09-30 | $370k | 9.6k | 38.39 |
| 2023-06-30 | $34k | 1.8k | 18.97 |
| 2023-03-31 | $321k | 21k | 15.41 |
| 2022-12-31 | $58k | 3.2k | 17.89 |
| 2022-09-30 | $65k | 12k | 5.52 |
| 2022-06-30 | $22k | 5.8k | 3.82 |
| 2022-03-31 | $57k | 10k | 5.47 |
| 2021-12-31 | $46k | 7.9k | 5.75 |
| 2021-09-30 | $88k | 10k | 8.58 |
| 2021-06-30 | $45k | 4.1k | 11.11 |
| 2021-03-31 | $92k | 5.7k | 16.05 |
| 2020-12-31 | $112k | 2.5k | 45.75 |
| 2020-09-30 | $140k | 3.9k | 35.35 |
| 2020-06-30 | $26k | 1.1k | 24.64 |